Sign In   |   Register
Candidates for the EAS Treasurer position
Share |

Paolo Parini was born in Rimini, Italy, in 1964. He gained his MD degree in 1990 at the Universita’ di Bologna, Italy. In 1994 he obtained his specialization in Gastroenterology and Hepatology (Universita’ di Bologna, Italy). The same year Paolo was registered as PhD-student at the Karolinska Institutet, Sweden, under the supervision of Prof Mats Rudling and Prof Bo Angelin.  In 1999, he obtained his PhD defending a thesis entitled “Hormonal regulation of hepatic cholesterol and lipoprotein metabolism: effects of estrogen and growth hormone” and since then his research activities are focused on the different aspect of lipoprotein metabolism in humans and in preclinical models.

Paolo’s postdoctoral activities have been performed at the Dept of Medicine, Karolinska Institutet, and in the lab of Prof Lawrence Rudel, Lipid Sciences, Wake Forest University School of Medicine Winston-Salem, NC, US.
In 2006, Paolo moved to the Dept of Laboratory Medicine, Karolinska Institutet, and created a research group together with Prof Mats Eriksson. From 2010 to 2016, Paolo Parini was the Director of the Division of Clinical Chemistry, Dept. of Laboratory Medicine, Karolinska Institutet. In 2011, he obtained the specialization in Clinical Chemistry (Swedish National Board of Health and Welfare) and in 2012 he become full professor in Clinical Chemistry at the Dept of Laboratory Medicine, Karolinska Institutet.

Since 2015, his professorship became “translational” being located 50% at the Dept of Laboratory Medicine and 50% at the Dept of Medicine, Karolinska Institutet.
Since January 2017, Paolo is also the Director of Research, Development, Education and Innovation at the Inflammation and Infection Theme, Karolinska University Hospital, Sweden. He is also member of the Board of Internationalization of the Karolinska Institutet and member of the
Scientific Committee of the Center E. Grossi Paoletti, Universita’ di Milano, Italy.  Paolo also coordinate the European project HUMAN (EU FP7 no 602757).

Paolo has represented Sweden in the Steering Committee of the European Lipoprotein Club (2005-2011) and is representing Sweden in the Steering Committee of the Scandinavian Society of Atherosclerosis Reseach since 2008. He has been the Chairman of the Scandinavian Society of Atherosclerosis Research between 2011 and 2015.

Paolo still see patients on regular basis at the Lipid Clinic of the Karolinska University Hopsital.

 

Katariina Öörni leads a research team at the Wihuri Research Institute, Helsinki, Finland, and she is Adjunct Professor of Biochemistry at the University of Helsinki.

Her research focuses on lipoprotein metabolism, retention, and accumulation of lipoprotein-derived lipids in the arterial wall. Her research group is particularly interested in modification and aggregation of LDL, and in the proinflammatory effects of the modified LDL particles. She has also been involved in 3-dimensional and molecular imaging of atherosclerotic lesions. The overall goal of her research program is to understand how accumulating lipoproteins trigger inflammatory responses in atherosclerosis.

Katariina Öörni is a council member of the Scandinavian Society for Atherosclerosis Research and of the Finnish Atherosclerosis Society, and also a member of the Organizing Committee of the European Lipoprotein Club. She is an Associate editor of Atherosclerosis, the official journal of EAS. She has been the secretary and treasurer of the Scandinavian Society for Atherosclerosis Research in 1998-2006.

VOTING IS NOW CLOSED

Membership Software Powered by YourMembership  ::  Legal